ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

OPTI Optibiotix Health Plc

15.25
-0.75 (-4.69%)
Last Updated: 09:00:24
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Optibiotix Health Plc LSE:OPTI London Ordinary Share GB00BP0RTP38 ORD 2P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.75 -4.69% 15.25 15.00 15.50 16.25 15.25 16.25 151,961 09:00:24
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Noncomml Resh Organizations 457k 2.59M 0.0284 5.37 13.91M
Optibiotix Health Plc is listed in the Noncomml Resh Organizations sector of the London Stock Exchange with ticker OPTI. The last closing price for Optibiotix Health was 16p. Over the last year, Optibiotix Health shares have traded in a share price range of 7.35p to 43.50p.

Optibiotix Health currently has 91,190,661 shares in issue. The market capitalisation of Optibiotix Health is £13.91 million. Optibiotix Health has a price to earnings ratio (PE ratio) of 5.37.

Optibiotix Health Share Discussion Threads

Showing 30526 to 30549 of 147875 messages
Chat Pages: Latest  1223  1222  1221  1220  1219  1218  1217  1216  1215  1214  1213  1212  Older
DateSubjectAuthorDiscuss
31/10/2017
14:42
Filter option very useful!!
moormoney
31/10/2017
14:32
risky

I thank you for trying to help with the summary.

However..I simply want to look at the full trial details myself.

I don't think that is unreasonable.

I am astonished that nobody on here has actually got the trial details when we have the likes of elrico writing all those reports for us.

chrisg11
31/10/2017
14:21
Anyone else use IG? Seems very odd... Quotes to buy 50,000 range from 73.99 but nearly every time it quotes 76p? To sell 50,000 it's 68.22p every single time without fail.
riskybusiness1
31/10/2017
14:11
Just another news article on the microbiome - good for PTSD now...
smegfish
31/10/2017
13:59
Rayrac legislation has become much tighter and now demands that any claim made with these types of products have solid evidence or risk being fined big time. It actually plays into the hands of Opti and is s huge window of opportunity you continue to ignore. HLH selling Lactobact LDL control which includes Optis LPLDL allows the marketing literature to say 'reduces cholesterol by up to 36%'. An established brand such as this clearly would not be able to make such a claim without the supporting evidence. You are now filtered
riskybusiness1
31/10/2017
13:09
Yep, mouse men filtered.
zebbo
31/10/2017
13:08
I think some of you boys are compensating for not being breastfed. Rayrac, opti science is good enough for fda approval, i suppose fda looked the otherway when asked for the science.
incanus
31/10/2017
13:07
Why should they be?
loungeact
31/10/2017
12:59
Because they have no requirement too.

And imo, they should be!

rayrac
31/10/2017
12:51
Tell us Rayrac...why aren't the results in the public domain? Enlighten us..
loungeact
31/10/2017
12:45
These guys like chris and rayrac are probably the mouse that's how sad he is. Filter the fools as they have nothing better to do with their time than come on here and trash the board!
primal123
31/10/2017
12:45
That’s why they are targeting them risky, any supposed trials dont come into the public domain!

It certainy can’t be because of competition, aren’t they supposed to have copyright?

Come on guys, work it out!

rayrac
31/10/2017
12:24
Chris, It was me who gave you the link to the Abstract. Anyone who can assure themselves that they have the credentials to decipher this type of information would have been able to work out the statistical significance that it showed. I note you mentioned nothing of the credentials of those who conducted the trials....but instead highlighted the insignificance of the study being of 49 subjects instead of 50. Sums you up really Rayrac - Will fail to register with you but Optibiotix are targeting the health and nutritional markets which actually require no scientific studies whatsoever. The business has been shaped round the emerging microbiome. The probiotic industry is a £40bn industry filled with products that have questionable science. The market is without doubt moving towards scientifically backed products driven by recent breakthroughs in this space and a better educated consumer.
riskybusiness1
31/10/2017
12:16
RNS dated 29 Sep 2015.

"The terms of the option agreement are bound by confidentiality and no further details on the agreement or human studies can be disclosed at this time."

Might be why the full trial results are not in the public domain.
If it were my company, I probably wouldn't release them either, if I thought the information would be advantageous to the competition.

hashertu
31/10/2017
11:56
Martin, OPTI is not just about weight management, it is much more diverse than that. There much better posters than me that can explain better.
slartybartfaster
31/10/2017
11:14
Parob - Also read this. Granted, it's not the most positive news for TATA etc but in ways it highlights the issues they have and how OPTI can potentially help with Sweetbiotix. --
loungeact
31/10/2017
11:11
OMG! Someone should warn TATA and SACCO etc!! lol
loungeact
31/10/2017
11:09
Another reason why the world needs SweetBiotix:

31/10/17



Rotten state of children's teeth in England exposed in hospital data

Last year there were 34,205 cases of under-10s receiving hospital treatment for tooth decay, twice as many as for broken arm

parob
31/10/2017
11:08
fyi #JOINUP

Ascent Resources Shareholder Action Group Launched!

Dan
x

daniel levi bmd
31/10/2017
11:01
No hope with that idea loungeact! It’s not available, just a summary. Trials? What trials?

It should be made to go through phase 1-2-3 trials . But as it doesn’t have to, then it’s open doors.

rayrac
31/10/2017
10:52
Loungeact..

Just a question.

Have you formulated all your opinions and invested heavily in this share without reading the trial?

I am just interested referencing your previous comments on research

chrisg11
31/10/2017
10:48
You should email SOH. Tell him you need more than the summary so you can fully analyse the results of the study.
loungeact
31/10/2017
10:47
loungeact
28596

:)

judijudi
31/10/2017
10:43
Thanks for your kind comments loungeact but as far as I can see that page is just a summary and not the full trial write up with detailed results.

I apologise for being thick but that is genetic and out of my control.

chrisg11
Chat Pages: Latest  1223  1222  1221  1220  1219  1218  1217  1216  1215  1214  1213  1212  Older